(Q35896154)

11 August 2017

1 reference

title

Cardiovascular risk and COX-2 inhibition in rheumatological practice (English)

1 reference

11 August 2017

Justice E

1

1 reference

PubMed ID

15385947

11 August 2017

Carruthers DM

series ordinal

2

1 reference

11 August 2017

1 January 2005

1 reference

Journal of Human Hypertension

11 August 2017

1 reference

11 August 2017

19

1 reference

11 August 2017

1

1 reference

11 August 2017

1-5

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1001777

11 August 2017

0 references

cites work

Cyclooxygenase-2 inhibition and renal physiology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

Impact of high-normal blood pressure on the risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

The coxibs, selective inhibitors of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

Cyclooxygenases, the kidney, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

Selective COX-2 inhibition improves endothelial function in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

Role of prostacyclin in the cardiovascular response to thromboxane A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

Effects of celecoxib and naproxen on renal function in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

inferred from DOI database lookup

7 January 2021

based on heuristic

Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001777

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.JHH.1001777

1 reference

11 August 2017

1 reference

PubMed ID

15385947